Fasting and post-glucose load measures of insulin resistance and risk of incident atrial fibrillation: The Cardiovascular Health Study

Nutr Metab Cardiovasc Dis. 2018 Jul;28(7):716-721. doi: 10.1016/j.numecd.2018.02.016. Epub 2018 Mar 2.

Abstract

Background and aims: Existing literature in individuals without diabetes has not demonstrated a relationship between IR and incident AF; however, data are limited and only fasting glucose measures of IR were assessed. We evaluated the relationship of both fasting and post-glucose load IR measures with the development of atrial fibrillation in nondiabetic older adults.

Methods and results: Among Cardiovascular Health Study participants, a population-based cohort of 5888 adults aged 65 years or older enrolled in two waves (1989-1990 and 1992-1993), those without prevalent AF or diabetes and with IR measures at baseline were followed for the development of AF, identified by follow-up visit electrocardiograms, hospital discharge diagnosis coding, or Medicare claims data, through 2014. Fasting IR was determined by the homeostatic model of insulin resistance (HOMA-IR) and post-glucose load IR was determined by the Gutt index. Cox proportional hazards models were used to determine the association of IR with risk of AF. Analyses included 3601 participants (41% men) with a mean age of 73 years. Over a median follow-up of 12.3 years, 1443 (40%) developed AF. After multivariate adjustment, neither HOMA-IR nor the Gutt index was associated with risk of developing AF [hazard ratios (95% confidence intervals): 0.96 (0.90, 1.03) for 1-SD increase in HOMA-IR and 1.03 (0.97, 1.10) for 1-SD decrease in the Gutt index].

Conclusions: We found no evidence of an association between either fasting or post-glucose load IR measures and incident AF.

Keywords: Atrial Fibrillation; Epidemiology; Insulin resistance.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / epidemiology*
  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Electrocardiography
  • Fasting / blood*
  • Female
  • Glucose Metabolism Disorders / blood*
  • Glucose Metabolism Disorders / diagnosis
  • Glucose Metabolism Disorders / epidemiology*
  • Glucose Metabolism Disorders / physiopathology
  • Glucose Tolerance Test
  • Humans
  • Incidence
  • Insulin Resistance*
  • Longitudinal Studies
  • Male
  • Prognosis
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • United States / epidemiology

Substances

  • Biomarkers
  • Blood Glucose